ALYSSA EZELL: Open Payments
NPI 1619381340 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,317 in 91 payments from 13 companies in 2025. Trend: 2023 $1,623 · 2024 $1,473 · 2025 $2,317
Food & beverage: $2,317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $1,020 |
| Janssen Biotech, Inc. | 24 | $541 |
| Madrigal Pharmaceuticals | 4 | $130 |
| Ardelyx, Inc. | 6 | $119 |
| Phathom Pharmaceuticals, Inc. | 8 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $109 |
| Janssen Scientific Affairs, LLC | 3 | $109 |
| Celltrion USA Inc. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Braintree Laboratories, Inc. | 1 | $34 |
Products named: TREMFYA, RINVOQ, SKYRIZI, REZDIFFRA, IBSRELA, VOQUEZNA, ENTYVIO, LINZESS.
Industry payments across AL — which companies pay providers there.
